Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0149514 (bronchitis)
 6,902 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

The authors report on a study of women taking oral contraceptives (OCs) to examine the effect of coadministration of the antibiotic ampicillin and to study the mechanism of interaction seen. 7 women between the ages of 19-27 were studied; all were on long-term OC therapy (5 with Eugynon 30, 1 with Ovranette, and 1 with Minovlar). 500 mg 3 times daily for 8 days was prescribed when 4 patients presented with cystitis and 3 patients with acute bronchitis. 6 volunteers between ages 21-24 who had been on long-term OC therapy for at least 3 months (5 with Eugynon 30 and 1 with Ovran) were studied. An identical dose regimen was provided for this group as well. Blood samples were centrifuged for 10 minutes at 2000 rev/minute. Plasma concentrations of ethinyl estradiol (EE), progesterone, FSH, and Ng were measured. Ampicillin concentrations in plasma were measured by a standard microbiological cup plate assay. No subjects displayed any side effects nor was there any evidence of disturbance in cycle control. Among the patients, the mean EE concentration was 46.4 +or- 15.2 pg/ml during ampicillin therapy and 60.2 +or- 4.8 pg/ml after ampicillin, a difference which is not statistically significant. Plasma levonorgestrel concentration was 2.0 +or- 0.3 ng/ml during ampicillin treatment and 2.05 +or- 0.4 ng/ml after (P0.05). FSH concentration during ampicillin was 2.1 +or- 0.3 mIU/ml and 2.05 +or- 0.5 mIU/ml (P0.05) after. Plasma progesterone concentrations did not exceed 200 pg/ml. Ampicillin concentration was not detectable in 4 of the patients. Among the volunteers, the mean plasma EE concentration was 31.4 +or- 5.0 pg/ml before ampicillin while it was 28.2 +or- 2.8 pg/ml during ampicillin therapy. Mean plasma levonorgestrel was 2.13 +or- 0.63 ng/ml before ampicillin and 2.00 +or- 0.59 ng/ml during ampicillin treatment. FSH concentration before ampicillin treatment was 1.12 +or- 0.23 mIU/ml while during ampicillin treatment, the figure was 0.93 +or- 0.27 mIU/ml. In this study, ampicillin had no significant effect on plasma concentrations of EE and levonorgestrel in women taking OCs. 2 recent studies have shown that ampicillin does not significantly interfere with OC therapy. It did not lower plasma OC concentrations and based on this, women taking OCs do not require alternative contraceptive precautions when taking ampicillin.
 ...
PMID:The effects of ampicillin on oral contraceptive steroids in women. 680 25

In an eight year period 16 cases of serious extrapulmonary Hemophilus influenzae infection in adults were identified, including cases of meningitis, pericarditis, epiglottitis, empyema, cellulitis, osteomyelitis, endometritis, urinary tract infection, orbital cellulitis, primary peritonitis, mesenteric lymphadenitis and aortic graft infection. An 18 month prospective study of H. influenzae infection in hospitalized adults identified 10 cases of bronchitis, 25 of pneumonia and 65 of respiratory tract colonization, but there were no extrapulmonary infections. In 29 percent of the respiratory tract infections, H. influenzae appeared to be a nosocomial pathogen; in 71 percent, the infection was mixed. Finally, 110 clinical isolates of H. influenzae were studied for antimicrobial susceptibility. Eight percent were ampicillin resistant, two strains were resistant to tetracycline and one to chloramphenicol, but all were susceptible to trimethoprim-sulfamethoxazole and cefamandole.
 ...
PMID:Hemophilus influenzae in hospitalized adults: current perspectives. 696 96

A total of 227 ambulatory patients who received prescriptions for antibiotics in a family practice residency program was studied. The common infections treated were urinary tract infections, upper respiratory tract infections, impetigo, nonspecific vaginitis, and bronchitis. Cultures obtained in 21.1 percent of the patients were usually considered to be appropriate. Urinary tract infections were usually treated with co-trimoxazole or other drugs containing sulfonamides; upper respiratory tract infections with amoxicillin, ampicillin, or penicillin; impetigo with penicillin; nonspecific vaginitis with vaginal creams; and bronchitis with ampicillin or erythromycin. Most prescriptions (86 percent) were written generically at an approximate savings of $2 per prescription. A review panel audited the prescribing practices and often (32.2 percent) disagreed among themselves, yet they did determine 65.4 percent of the prescriptions to be appropriate. The rate of appropriate antibiotic prescribing practices among the residents was found to decrease as the level of supervision decreased (P less than 0.01).
 ...
PMID:Antibiotic prescribing in a family medicine residency program. 708 72

This report describes a single-blind, comparative evaluation of cefaclor and tetracycline therapy for acute episodes of bacterial bronchitis due to Hemophilus influenzae or Streptococcus pneumoniae. One therapeutic failure occurred in the 25 patients receiving cefaclor, and four occurred in the 26 patients receiving tetracycline. The latter failures were due to tetracycline-resistant organisms. Sputum cultures yielded 39 isolates of S pneumoniae and 11 of H influenzae. None of the isolates were resistant to cefaclor. In contrast, the incidence of resistance to tetracycline was 38% (18 of 48 isolates). All of the nine isolates of H influenzae tested were resistant to tetracycline; five of 11 H influenzae isolates were resistant to ampicillin, four of four were resistant to erythromycin, and five strains were resistant to multiple agents. These findings suggest that traditional therapy of bacterial bronchitis may be unsatisfactory in a substantial proportion of patients. The high cure rate and the absence of resistance found in the present study indicate that cefaclor is preferable to tetracycline in the treatment of bacterial bronchitis.
 ...
PMID:Clinical and bacteriological evaluation of cefaclor and tetracycline in acute episodes of bacterial bronchitis. 715 94

Studies on antimicrobial activity, absorption and excretion and clinical use of cefoxitin in pediatric field were performed. 1. MIC of cefoxitin was compared with that of cefazolin and/or ampicillin for clinical isolates of Staphylococcus aureus (36 strains), Escherichia coli (35 strains), Klebsiella pneumoniae (34 strains) and Haemophilus influenzae (80 strains). MIC of cefoxitin against S. aureus was approximately 1-2 tubes higher than that of cefazolin. Many strains of E. coli and K. pneumoniae that showed high MIC to cefazolin were sensitive to cefoxitin. It is presumed that the results are due to the strong resistance of cefoxitin to beta-lactamase degradation. MIC of cefoxitin against H. influenzae was approximately 1-2 tubes lower than that of cefazolin, but approximately 4 tubes higher than that of ampicillin. 2. Serum level and urinary recovery rate of cefoxitin after one shot i.v. injection of 25 mg/kg were examined. The serum mean levels were 33.8 microgram/ml at 1/2 hour, 7.0 microgram/ml at 1 hour and 2.9 microgram/ml at 2 hours after the injection, respectively, and the drug was not detected in serum at 4 and 6 hours after the injection. The mean half-life of serum level was 27.1 minutes. The mean urinary recovery rate within 6 hours after injection was 96.0% and most of the drug were excreted into urine within 2 hours after the injection. 3. In order to evaluate clinical response, bacteriological response and side effects, cefoxitin was applied to 19 cases, i.e., 12 cases of either acute lobar pneumonia or acute bronchopneumonia, 2 cases of acute pyelitis, 1 case each of acute bronchitis, acute purulent tonsillitis, acute purulent arthritis, acute orbital phlegmon and acute buccal abscess. As for clinical response, the overall efficacy rate (the percentage of cases showed excellent and good efficacy) was 88.9%. As for bacteriological response, among the 13 strains which were determined or supposed to be causative organisms, i.e., 6 strains of Streptococcus pneumoniae, 2 strains of H. influenzae and 1 strain each of streptococcus pyogenes, alpha-Streptococcus, Enterococcus, E. coli and Neisseria sp., all strains were disappeared except for Enterococcus which was reduced by the treatment with cefoxitin. No side effect was observed in any case. Abnormalities of laboratory findings were observed in 3 cases, i.e., 1 case each of reduction of RBC and Hb, elevation of GOT and GPT and elevation of GPT, but all of them returned to normal following completion of the dosage term.
 ...
PMID:[Laboratory and clinical studies on cefoxitin in pediatric field (author's transl)]. 728 22

The pattern of distribution of bacteria, Mycoplasma pneumoniae and virus isolated from the same specimen recovered from the throat swab or the sputum of 479 patients with respiratory infections who were seen in six private clinics in Sendai City of Japan during the period from October to November in 1992 (period I) and from January to February in 1993 (period II) was documented. Of the 479 patients, 234 had acute pharyngitis, 145 had acute bronchitis, 96 had influenza, 21 had acute tonsillitis, 5 had acute pneumonia and 9 had other respiratory infections. One hundred (42.4%) strains of potential pathogen and one strain of M. pneumoniae were recovered from 236 cases in period I, and 66 (27.2%) strains of potential pathogen, one strain of M. pneumonae and 73 strains of Influenza virus (30.0%: 43 of type A Hong-Kong and 30 of type B) from 243 cases in period II. Of the 166 strains, major isolates were Staphylococcus aureus (56 strains), Streptococcus pneumoniae (12 strains), Streptococcus pyogenes (15 strains), Haemophilus influenzae (17 strains), Esherichia coli (4 strains), Klebsiella spp. (35 strains), Pseudomonas aeruginosa (4 strains) and Acinetobacter spp. (23 strains). Only one strain of S. aureus was resistant to methicillin (MIC: 50 micrograms/ml). None of S. pneumoniae was resistant to 1 microgram/ml of ampicillin. Ciprofloxacin was administered to 113 cases and roxythromycin to 220 cases by doctors in charge.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:[Studies on respiratory infections in primary care clinic (V). The pattern of distribution on bacteria, Mycoplasma pneumoniae and virus isolated from patients with respiratory infections, who were seen in six private clinics, and clinical efficacy of ciprofloxacin and roxithromycin]. 782 4

Antibiotic susceptibility of 279 strains of gram-positive and gram-negative isolates from patients with bronchopulmonary infections was tested. It was shown that the frequency of resistance to ampicillin and sulacillin amounted to 36.5 and 28.8 per cent respectively. The highest clinical efficacy of sulacillin was observed in the treatment of acute pneumonia (good and satisfactory results in 76.2 and 19 per cent of the cases respectively) and chronic nonobstructive bronchitis (good and satisfactory results in 80 and 16 per cent respectively). The clinical efficacy of sulacillin was somewhat lower in the treatment of chronic obstructive bronchitis (good and satisfactory results in 50 and 30 per cent of the cases respectively). In the treatment of chronic purulent bronchitis no clinical effect was detected in 30 per cent of the cases and in 70 per cent of the cases the results were satisfactory. The total frequency of adverse reactions to sulacillin amounted to 18.8 per cent.
 ...
PMID:[Sulacillin in the treatment of bronchopulmonary diseases]. 797 95

In a randomized prospective study, ampicillin (AMP) in combination with the beta-lactamase-inhibitor, sulbactam (SBT) was compared with cefuroxime (CXM) in 73 hospitalized patients with lower respiratory tract infections. 36 patients received SBT/AMP 1 g/2 g t.i.d. and 37 patients received CXM 1.5 g t.i.d.--both in the form of i.v. infusion. The duration of treatment ranged from five to twelve days, with a median of eight days in each group. 23 patients (64%) of the SBT/AMP group had pneumonia, while 13 (36%) had acute purulent bronchitis; 13 of the patients (36%) received artificial respiration. 23 patients (62%) of the CXM group had pneumonia and 14 (38%) acute purulent bronchitis; eight patients (22%) required artificial respiration. In 54 patients (SBT/AMP: 26; CXM: 28) initial culture yielded bacterial pathogens, mainly Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Staphylococcus aureus and pneumococci. 35 patients in each group were clinically evaluable. 31 patients (89%) responded to treatment with SBT/AMP, and 28 patients (80%) to treatment with CXM. Four patients (11%) who received SBT/AMP failed to respond, as did seven patients on CXM. The bacteriological efficacy was assessed in 26 patients of the SBT/AMP group: in 22 cases (84%) baseline pathogens were eradicated, while in two patients (8%) each, there was persistent infection and a superinfection, respectively. In 23 patients (82%) of the CXM group (28 patients evaluated) the pathogens were eradicated, while three cases (11%) had persistent infection, and two (7%) superinfection. Apart from a case of exanthema under CXM, no adverse drug reactions were reported. No statistically significant differences were to be seen between the two groups.(ABSTRACT TRUNCATED AT 250 WORDS)
 ...
PMID:[Sulbactam/ampicillin in comparison with cefuroxime for infections of the lower respiratory tract. Results of a prospective, randomized comparative study]. 843 27

Only scanty data are available on the susceptibility of Haemophilus influenzae in Italy. The in vitro activity of ampicillin, ampicillin-sulbactam, cefaclor, cefuroxime, cefotaxime, chloramphenicol, erythromycin and trimethoprim-sulfamethoxazole against 327 strains of Haemophilus influenzae (55 encapsulated, 272 non-typeable) isolated from adults and children in northern Italy, between January 1984 and December 1989, was compared. Patients were affected by meningitis or other invasive infections, conjunctivitis, otitis, sinusitis, pneumonia or bronchitis. Minimal inhibiting concentrations were determined by a microdilution technique in Mueller Hinton broth supplemented with 10 microliters/ml NAD and 2-5% lysed horse blood. A concentration of 1 x 10(5) to 5 x 10(5) CFU/ml was used as the inoculum. The antibiotics were tested at concentrations ranging from 0.03 to 64 microliters/ml with the exception of trimethoprim-sulfamethoxazole, for which the range of concentrations examined were 0.01/0.25 to 32/512 microliters/ml. All the strains tested were susceptible to ampicillin-sulbactam, cefuroxime and cefotaxime, and more than 95% were susceptible to ampicillin, cefaclor and chloramphenicol. Only 4% were susceptible to erythromycin but most minimal inhibiting concentrations fell into the intermediate category. Strains isolated from adults were more susceptible to trimethoprim-sulfamethoxazole than strains isolated from children (85% vs 66%; p = 0.011).
 ...
PMID:Antimicrobial resistance among clinical isolates of Haemophilus influenzae in northern Italy. Collaborative Study on Pediatric Infectious Diseases. 847 3

The antimicrobial susceptibility patterns of 76 nonserotypable Haemophilus influenzae (biotypes I-IV) from patients with chronic bronchitis were compared against ten orally administered antimicrobial agents. In addition the sputum ampicillin concentrations one hour after standard therapy were determined in five patients with chronic bronchitis. Ampicillin resistance was demonstrated in one strain (biotype IV) which produced beta-lactamase and two strains (biotype II) with innate resistance (MIC = 4 mg/l). Resistance to trimethoprim, chloramphenicol, ciprofloxacin and cefaclor was not detected. The incidence of resistance to tetracycline was 0.5% and cephalexin 13.2%. A high incidence of resistance to erythromycin (95%) was noted. There was no association between resistance and biotype of nonserotypable H. influenzae. The sputum ampicillin concentrations from four out of five patients given standard antibiotic doses were shown to be sufficient to inhibit the growth of the majority of nonserotypable H. influenzae strains one hour after treatment. This study shows that the incidence of nonserotypable H. influenzae resistant to ampicillin is low in this community but that resistance levels to erythromycin, commonly prescribed for the management of acute bronchitis, are high. Regular sensitivity screens are important in monitoring the value of various antibiotic regimens in the management of acute bronchitis.
 ...
PMID:In vitro susceptibility patterns of nonserotypable Haemophilus influenzae from patients with chronic bronchitis. 909 83


<< Previous 1 2 3 4 5 6 7 8 Next >>